Topical Nasal Corticosteroids During the Common Cold in Allergic Rhinitis Patients
Do not use topical nasal corticosteroids for symptomatic relief during the common cold, even in patients with a history of allergic rhinitis—there is no evidence supporting their efficacy for viral upper respiratory infections. 1
Evidence-Based Recommendation
The European Rhinologic Society explicitly states that there is currently no evidence to support the use of intranasal corticosteroids for symptomatic relief from the common cold. 1 This applies regardless of whether the patient has underlying allergic rhinitis.
Key Distinction: Allergic Rhinitis vs. Viral Infection
For allergic rhinitis symptoms: Intranasal corticosteroids remain the most effective medication class for controlling sneezing, itching, rhinorrhea, and nasal congestion through their anti-inflammatory activity. 1
For common cold symptoms: The mechanism of action—suppressing allergic inflammation by reducing eosinophils, mast cells, and cytokine production—does not address the viral pathophysiology of the common cold. 2, 3
What Actually Works for the Common Cold
Short-term topical decongestants (3 days maximum) are appropriate for nasal congestion associated with acute viral infections, though patients must be warned about rhinitis medicamentosa risk with longer use. 1
Antihistamines, analgesics, and decongestants (alone or in combination) have some general benefit in adults and older children with common cold, though benefits must be weighed against adverse effects. 1
Critical Clinical Pitfall
Do not confuse an acute exacerbation of allergic rhinitis triggered by allergen exposure with a common cold. If a patient with allergic rhinitis develops nasal symptoms during cold season, consider whether this represents:
- True viral infection: Intranasal corticosteroids will not help 1
- Allergic exacerbation: Continue or intensify intranasal corticosteroids 1, 4, 5
- Both conditions simultaneously: Treat the allergic component with intranasal corticosteroids while using symptomatic measures (decongestants, analgesics) for the viral symptoms 1
Practical Management Algorithm
For patients with allergic rhinitis who develop upper respiratory symptoms:
- Assess symptom pattern: Viral symptoms typically include systemic features (fever, myalgias, sore throat), purulent discharge, and acute onset over 24-48 hours
- Continue baseline intranasal corticosteroids if the patient was already using them for allergic rhinitis maintenance 5
- Add short-term topical decongestants (≤3 days) for severe nasal obstruction to maintain nasal patency 1
- Do not initiate intranasal corticosteroids specifically for cold symptom relief 1
Safety Consideration
While intranasal corticosteroids at recommended doses have no clinically significant systemic effects and can be used long-term for allergic rhinitis, 4, 5 their lack of efficacy for viral infections makes their use during the common cold both unnecessary and potentially misleading to patients about appropriate cold management. 1